BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossi SH, Prezzi D, Kelly-Morland C, Goh V. Imaging for the diagnosis and response assessment of renal tumours. World J Urol 2018;36:1927-42. [PMID: 29948048 DOI: 10.1007/s00345-018-2342-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Niu X, Wang L, Li Y, Qiao B. Comparison of survival between unilocular cystic and purely solid renal cell carcinoma. Sci Rep 2022;12:12865. [PMID: 35896562 DOI: 10.1038/s41598-022-16856-2] [Reference Citation Analysis]
2 Wu Q, Huang G, Wei W, Liu J. Molecular Imaging of Renal Cell Carcinoma in Precision Medicine. Mol Pharm 2022. [PMID: 35510710 DOI: 10.1021/acs.molpharmaceut.2c00034] [Reference Citation Analysis]
3 Mohamed AH, Abdullahi IM, Eraslan A, Mohamud HA, Gur M. Epidemiological and Histopathological Characteristics of Renal Cell Carcinoma in Somalia. CMAR 2022;Volume 14:1837-44. [DOI: 10.2147/cmar.s361765] [Reference Citation Analysis]
4 Ljungberg B, Albiges L, Abu-ghanem Y, Bedke J, Capitanio U, Dabestani S, Fernández-pello S, Giles RH, Hofmann F, Hora M, Klatte T, Kuusk T, Lam TB, Marconi L, Powles T, Tahbaz R, Volpe A, Bex A. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. European Urology 2022. [DOI: 10.1016/j.eururo.2022.03.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 27.0] [Reference Citation Analysis]
5 Medline A, Nabavizadeh R, Le T, Patil D, Evans S, Sandberg A, Psutka SP, Master VA. Magnetic resonance imaging vs. computed tomography image concordance for linear measurements and the quantification of abdominal skeletal muscle. JCSM Clinical Reports 2022;7:24-9. [DOI: 10.1002/crt2.46] [Reference Citation Analysis]
6 Tariq A, Kwok M, Pearce A, Rhee H, Kyle S, Marsh P, Raveenthiran S, Wong D, McBean R, Westera J, Dunglison N, Esler R, Navaratnam A, Yaxley JW, Thomas P, Pattison DA, Roberts MJ. The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison. Urol Oncol 2021:S1078-1439(21)00502-0. [PMID: 34895817 DOI: 10.1016/j.urolonc.2021.11.006] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Zuo T, Zheng Y, He L, Chen T, Zheng B, Zheng S, You J, Li X, Liu R, Bai J, Si S, Wang Y, Zhang S, Wang L, Chen J. Automated Classification of Papillary Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma Based on a Small Computed Tomography Imaging Dataset Using Deep Learning. Front Oncol 2021;11:746750. [PMID: 34868946 DOI: 10.3389/fonc.2021.746750] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Grajo JR, Batra NV, Bozorgmehri S, Magnelli LL, O'Malley P, Terry R, Su LM, Crispen PL. Association between nuclear grade of renal cell carcinoma and the aorta-lesion-attenuation-difference. Abdom Radiol (NY) 2021;46:5629-38. [PMID: 34463815 DOI: 10.1007/s00261-021-03260-z] [Reference Citation Analysis]
9 Kubiliūtė R, Žukauskaitė K, Žalimas A, Ulys A, Sabaliauskaitė R, Bakavičius A, Želvys A, Jankevičius F, Jarmalaitė S. Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma. J Cancer Res Clin Oncol 2021. [PMID: 34689221 DOI: 10.1007/s00432-021-03837-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Dispagna MA, Daneshvar M, Bratslavsky G. Surgical Insights for the Management of Variant Histology in Renal Cell Carcinoma. Int Braz J Urol 2021;47:935-42. [PMID: 33650834 DOI: 10.1590/S1677-5538.IBJU.2020.0778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Abou Elkassem AM, Lo SS, Gunn AJ, Shuch BM, Dewitt-Foy ME, Abouassaly R, Vaidya SS, Clark JI, Louie AV, Siva S, Grosu AL, Smith AD. Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective. Radiographics 2021;:200202. [PMID: 34270355 DOI: 10.1148/rg.2021200202] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
12 Grajo JR, Batra NV, Bozorgmehri S, Magnelli LL, Pavlinec J, O'Malley P, Su LM, Crispen PL. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors. Abdom Radiol (NY) 2021;46:3269-79. [PMID: 33665734 DOI: 10.1007/s00261-021-02971-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Li M, Song X, Jin S, Ye K. 3D tumor model biofabrication. Bio-des Manuf 2021;4:526-40. [DOI: 10.1007/s42242-021-00134-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Poon DM, Chan CK, Chan K, Chu WH, Kwong PW, Lam W, Law KS, Lee EK, Liu PL, Sze HC, Wong JH, Chan ES. Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology 2019. Asia Pac J Clin Oncol 2021;17 Suppl 3:27-38. [PMID: 33860644 DOI: 10.1111/ajco.13581] [Reference Citation Analysis]
15 Mühlbauer J, Egen L, Kowalewski KF, Grilli M, Walach MT, Westhoff N, Nuhn P, Laqua FC, Baessler B, Kriegmair MC. Radiomics in Renal Cell Carcinoma-A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:1348. [PMID: 33802699 DOI: 10.3390/cancers13061348] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
16 Bertelli E, Palombella A, Sessa F, Baldi I, Morelli N, Verna S, Greco I, Morselli S, Pili A, Sebastianelli A, Berni A, Nicoletti R, Minervini A, Carini M, Gacci M, Miele V, Agostini S, Serni S, Campi R. Contrast-enhanced ultrasound (CEUS) imaging for active surveillance of small renal masses. World J Urol 2021;39:2853-60. [PMID: 33495864 DOI: 10.1007/s00345-021-03589-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Sung WW, Ko PY, Chen WJ, Wang SC, Chen SL. Trends in the kidney cancer mortality-to-incidence ratios according to health care expenditures of 56 countries. Sci Rep 2021;11:1479. [PMID: 33446693 DOI: 10.1038/s41598-020-79367-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Spiesecke P, Fischer T, Friedersdorff F, Hamm B, Lerchbaumer MH. Quality Assessment of CEUS in Individuals with Small Renal Masses-Which Individual Factors Are Associated with High Image Quality? J Clin Med 2020;9:E4081. [PMID: 33348741 DOI: 10.3390/jcm9124081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Khandwala K, Khan DB, Hussain Z, Sajjad N, Alvi MI. Interobserver Reliability of the RENAL Nephrometry Scoring System: Experience From a Developing Nation. Cureus 2020;12:e11451. [PMID: 33329950 DOI: 10.7759/cureus.11451] [Reference Citation Analysis]
20 Li CX, Lu Q, Huang BJ, Wang PL, Wang WP. Routine or enhanced imaging to differentiate between type 1 and type 2 papillary renal cell carcinoma. Clin Radiol 2021;76:135-42. [PMID: 33092815 DOI: 10.1016/j.crad.2020.09.020] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Yin R, Jiang M, Lv WZ, Jiang F, Li J, Hu B, Cui XW, Dietrich CF. Study Processes and Applications of Ultrasomics in Precision Medicine. Front Oncol 2020;10:1736. [PMID: 33014858 DOI: 10.3389/fonc.2020.01736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
22 Meng X, Xiong Z, Xiao W, Yuan C, Wang C, Huang Y, Tong J, Shi J, Chen Z, Liu C, Xie K, Xiong H, Chen K, Yang H, Zhang X. Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression. Ann Transl Med 2020;8:319. [PMID: 32355763 DOI: 10.21037/atm.2020.02.141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
23 Voss J, Drake T, Matthews H, Jenkins J, Tang S, Doherty J, Chan K, Dawe H, Thomas T, Kearley S, Manners J, Carter C, Al-Buheissi S, Klatte T. Chest computed tomography for staging renal tumours: validation and simplification of a risk prediction model from a large contemporary retrospective cohort. BJU Int 2020;125:561-7. [PMID: 31955483 DOI: 10.1111/bju.15001] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Joe WB, Zarzour JG, Gunn AJ. Renal Cell Carcinoma Ablation: Preprocedural, Intraprocedural, and Postprocedural Imaging. Radiol Imaging Cancer 2019;1:e190002. [PMID: 33778679 DOI: 10.1148/rycan.2019190002] [Reference Citation Analysis]
25 van Oostenbrugge TJ, Langenhuijsen JF, Oosterwijk E, Boerman OC, Jenniskens SF, Oyen WJG, Fütterer JJ, Mulders PFA. Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with 111In-girentuximab. Eur J Nucl Med Mol Imaging 2020;47:1864-70. [PMID: 31768601 DOI: 10.1007/s00259-019-04613-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Peisen F, Thaiss W, Tietze N, Rausch S, Amend B, Nikolaou K, Bedke J, Stenzl A, Kaufmann S. [Influence of immunomodulators on urological imaging]. Urologe A 2019;58:1451-60. [PMID: 31705144 DOI: 10.1007/s00120-019-01063-1] [Reference Citation Analysis]
27 Raveenthiran S, Esler R, Yaxley J, Kyle S. The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma. Eur J Nucl Med Mol Imaging 2019;46:2280-8. [DOI: 10.1007/s00259-019-04432-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
28 Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernández-Pello S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Tahbaz R, Volpe A, Bex A. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update. Eur Urol 2019;75:799-810. [PMID: 30803729 DOI: 10.1016/j.eururo.2019.02.011] [Cited by in Crossref: 383] [Cited by in F6Publishing: 581] [Article Influence: 127.7] [Reference Citation Analysis]
29 Rossi SH, Blick C, Handforth C, Brown JE, Stewart GD; Renal Cancer Gap Analysis Collaborative. Essential Research Priorities in Renal Cancer: A Modified Delphi Consensus Statement. Eur Urol Focus 2020;6:991-8. [PMID: 30772357 DOI: 10.1016/j.euf.2019.01.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
30 Khan AI, Reiter DA, Sekhar A, Sharma P, Safdar NM, Patil DH, Psutka SP, Small WC, Bilen MA, Ogan K, Master VA. MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurement. Appl Physiol Nutr Metab 2019;44:814-9. [PMID: 30615474 DOI: 10.1139/apnm-2018-0473] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
31 Klatte T, Stewart GD. Renal cell carcinoma: standards and controversies. World J Urol 2018;36:1889-90. [DOI: 10.1007/s00345-018-2490-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]